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Abstract
Chronic cerebral hypoperfusion is a key mechanism associated with white matter disruption in cer-
ebral vascular disease and dementia. In a mouse model relevant to studying cerebral vascular
disease, we have previously shown that cerebral hypoperfusion disrupts axon-glial integrity and
the distribution of key paranodal and internodal proteins in subcortical myelinated axons. This dis-
ruption of myelinated axons is accompanied by increased microglia and cognitive decline. The aim
of the present study was to investigate whether hypoperfusion impairs the functional integrity of
white matter, its relation with axon-glial integrity and microglial number, and whether by targeting
microglia these effects can be improved. We show that in response to increasing durations of
hypoperfusion, the conduction velocity of myelinated fibres in the corpus callosum is progressively
reduced and that paranodal and internodal axon-glial integrity is disrupted. The number of micro-
glial cells increases in response to hypoperfusion and correlates with disrupted paranodal and
internodal integrity and reduced conduction velocities. Further minocycline, a proposed anti-
inflammatory and microglia inhibitor, restores white matter function related to a reduction in the
number of microglia. The study suggests that microglial activation contributes to the structural and
functional alterations of myelinated axons induced by cerebral hypoperfusion and that dampening
microglia numbers/proliferation should be further investigated as potential therapeutic benefit in
cerebral vascular disease.
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1 | INTRODUCTION
Subcortical white matter is disrupted in cerebral vascular disease and
dementia. Cerebral hypoperfusion is often linked with pathological
changes in white matter (O’Sullivan et al., 2002) which have been
detected using imaging approaches in vivo such as diffusion tensor
imaging (Bastin et al., 2009; Benjamin et al., 2015; Bucur et al., 2008).
Neuropathological investigations have also revealed marked alterations
in white matter including reductions in myelin density in vascular
disease (Barker, Wellington, Esiri, & Love, 2013; Ihara et al., 2010) with
evidence that this may be related to reduced white matter perfusion
(Barker et al., 2014; Fernando et al., 2006). Importantly the extent and
presence of these white matter changes are now considered to be
important determinants of cognitive function and influence dementia
(Chen et al., 2016; Prins & Scheltens, 2015).
We and others have shown using experimental models of cere-
bral hypoperfusion that the brain’s white matter is particularly vulner-
able to modest reductions in blood flow. Specifically, reduced cerebral
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perfusion elicits diffuse damage to myelinated axons accompanied by
a pronounced pro-inflammatory response and impaired spatial work-
ing memory. (Coltman et al., 2011; Holland et al., 2011, 2015;
McQueen, Reimer, Holland, & Horsburgh, 2014; Reimer et al., 2011;
Shibata, Ohtani, Ihara, & Tomimoto, 2004) Moreover, hypoperfusion
leads to the disruption of key paranodal and internodal proteins
which are essential for the stability of the axon-glial connection
(Reimer et al., 2011). Myelinated axons have a unique and highly
organized molecular structure that enables rapid and efficient action
potential propagation (Hartline and Colman, 2007). Alterations in
axon-glial integrity and disruption of the protein architecture of nodal
regions have been shown to impair axonal function (Boyle et al.,
2001; Nie et al., 2006; Pillai et al., 2009; Ritter et al., 2013). Indeed,
recent mathematical modelling indicates that subtle paranodal disrup-
tion is sufficient to significantly slow axonal conduction velocity i.e.,
the speed at which action potentials propagate along myelinated
axons (Babbs and Shi, 2013). As yet mechanisms linking subtle reduc-
tions in blood flow to axon-glial alterations are unknown as are the
impacts this has on axonal function.
Microglia are the resident immune cells of the brain and, in
response to injury, secrete various factors such as cytokines and che-
mokines that can modulate the pathological outcome. Increased num-
bers of microglia often accompany damage to myelinated axons in
rodent models of hypoperfusion (Coltman et al., 2011; McQueen et al.,
2014; Reimer et al., 2011). Similarly increased numbers of microglia
have been identified in white matter lesions in aged post-mortem
human brain (Simpson et al., 2007). Activated microglia (defined by
their altered morphology and increased expression of pro-inflammatory
genes) predominate in the white matter of aged primate brain and cor-
relate with cognitive impairment (Sloane, Hollander, Moss, Rosene, &
Abraham, 1999). Increased numbers of activated microglia have also
been linked to axon-glial disruption in an experimental model of multi-
ple sclerosis (Howell et al., 2010). It is not clear, however, whether
these changes in microglia number or phenotype contribute to, or are
consequence of, the damage to myelinated axons. Potential anti-
inflammatory agents or drugs that inhibit microglia, such as minocy-
cline, can exert a protective effect on white matter structure as a con-
sequence of hypoperfusion (Choe et al., 2006; Ma et al., 2015) and
hypoperfusion/hypertension (Jalal et al., 2015). However to date it is
not known whether minocycline has a protective effect on white mat-
ter function and if this is related to microglia.
The aim of the present study was to investigate whether, in
response to increased durations of hypoperfusion, the functional integ-
rity of white matter is impaired and related to axon-glial integrity and
microglia numbers/proliferation. Second to this we tested the potential
protective effect of minocycline on white matter function and microglia
numbers/proliferation.
2 | MATERIALS AND METHODS
2.1 | Animal cohorts
All experiments were conducted under the UK Home Office Animals
(Scientific Procedures) Act 1986, in agreement with local ethical and
veterinary approval (Biomedical Research Resources, University of
Edinburgh) and the ARRIVE guidelines. Adult (25–30 g) male C57Bl/6J
mice (Charles River Laboratories Inc, UK) were used for all experiments.
At the outset, mice were coded and randomly assigned to experimental
groups and investigators were blinded to the surgical or drug interven-
tion. In Study 1, to assess temporal alterations in white matter function,
mice were allocated to sham or hypoperfusion surgery to be studied at
either 1, 6, or 12 weeks after surgery (12 sham and 12–13 hypoper-
fused mice per time-point). In Study 2, to assess the effect of minocy-
cline treatment, mice were assigned to hypoperfusion or sham surgery
and treatment with either vehicle sham (n510) or hypoperfusion vehi-
cle (n511) or minocycline (n59). The majority of the mice had a good
recovery but those that had a poor recovery were excluded from the
study (study 1; 1 week n53 and 12 weeks n53 hypoperfusion; Study
2 all mice recovered well). In Study1, one animal from the 6 week
cohort was excluded and in Study 2 two mice (one sham and one
hypoperfusion vehicle) were excluded as electrophysiological record-
ings were unable to be measured. This resulted in final cohort sizes as
follows: Study 1—1 week (sham n512; hypoperfusion n59); 6 weeks
(sham n512; hypoperfusion n512); 12 weeks (sham n512; hypoper-
fusion n59). Study 2 vehicle sham (n59) or hypoperfusion vehicle
(n510) or hypoperfusion minocycline (n59).
2.2 | Chronic cerebral hypoperfusion and minocycline
treatment
Chronic cerebral hypoperfusion was induced by bilateral carotid artery
stenosis as previously described (Coltman et al., 2011; Reimer et al.,
2011). Briefly, 0.18 mm internal diameter microcoils (Sawane Spring Co,
Shizuoka, Japan) were fitted on both common carotid arteries under iso-
flurane anaesthesia (induced at 5% and maintained at 1.2%–1.6%). A 30
minute interval was left between the placement of the first and second
coil. Sham mice underwent the exact same surgical procedure with the
exception that coils were not applied to the arteries. Animals were
housed with free access to food and water in a 12-h dark-light cycle
under constant temperature and carefully monitored throughout the
experiment. Minocycline (Sigma) or vehicle was injected at a dose of
50 mg/kg,ip every other day for 10 weeks starting from day 1 after
hypoperfusion surgery. This mode of drug administration was under-
taken in order that we could control the dose of minocycline each mouse
received. The mice habituated readily to this mode of injection. The
researchers were blind to the drug administered and surgery.
2.3 | Tissue collection
At defined survival times after surgery, mice were sacrificed and their
brains were quickly removed on top of a frozen petri-dish with a few
drops of sucrose artificial cerebrospinal fluid, aCSF, (189 mM Sucrose,
10 mM D-glucose, 26 mM NaHCO3, 3mM KCl, 5mM MgCl2, 0.1 mM
CaCl2, 1.25mM NaH2PO4). The brain was then rapidly dissected,
placed in a cell strainer, and submerged in ice-cold oxygenated (carbo-
gen 95% O2, 5% CO2, BOC, UK) sucrose aCSF for 2–3 minutes. The
brain was then glued to the cooled specimen block after carefully
removing the cerebellum, transferred to the cutting chamber and
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submerged in oxygenated ice-cold sucrose aCSF. Sections were then
cut at 400 mm using a vibrating blade microtome (Hydrax V50, Zeiss,
Cambridge, UK). A single coronal slice (in the region of 21.2 to 1.7 mm
Bregma) was then transferred to a warmed (348C) incubation chamber
(BSK1, Digitimer, Welwyn Garden City, UK) with oxygenated aCSF
(124 mM NaCl, 5 mM KCL, 1.25 mM NaH2PO4, 26 mM NaHCO3,
1.3 mM MgSO4, 2 mM CaCl2, 10 mM D-Glucose) for one hour before
electrophysiological recording. An adjacent 1.5 mm thick slice, to that
of the recording slice, was cut and immediately post-fixed for 24 h in
4% paraformaldehyde, rinsed in phosphate buffer and processed for
paraffin embedding.
2.4 | Electrophysiology
Recording procedures were similar to those previously published
(Crawford et al., 2009). Briefly, following at least a 1 hour period of
post-slicing recovery slices were carefully transferred to a recording
chamber (RC27L, Harvard Apparatus, Cambridge, UK) mounted on an
Olympus BX51 microscope (Olympus, KeyMed House, Southend-on-
Sea, UK) where they were superfused with oxygenated aCSF (2–3 ml/
min) at 248C. This temperature was employed to enable discrimination
of compound actions potentials arising from myelinated and unmyeli-
nated fibres. Slices were supported by a slice anchor and then allowed
to rest for 30 minutes prior to recording. A bipolar stimulating elec-
trode (WPI Inc, Hertfordshire, UK) with manually blunted tips was low-
ered into the corpus callosum 1 mm lateral to the midline using a
manual manipulator and constant current stimulus-isolated square
wave pulses (NL800, Digitimer, Welwyn Garden City, UK) were applied
to evoke compound action potentials (CAP). Recording electrodes
were pulled from borosilicate glass capillaries (1.5/0.84 mm OD/ID,
100 mm long, WPI Inc., Hertfordshire, UK) and back filled with aCSF to
give a final resistance of 1–3MX. These were connected to the ampli-
fier’s headstage via an Ag/AgCl wire and then lowered into the corpus
callosum (Patchstar micromanipulator, Scientifica, East Sussex, UK)
adjacent to the midline 2 mm contralateral to the stimulating electrode.
For analysis of the CAP peak amplitude standardised input-output
functions were generated by varying the intensity of stimulus pulse
(200 ls duration, 0.2 Hz) in 0.25 mA increments from 0.25–4 mA. To
enhance the signal to noise ratio, all electrophysiology analysis was
conducted on averaged waveforms of four successive sweeps. Evoked
CAPs were amplified (3500) and filtered (bandpass5DC to 10 kHz)
using an Axopatch 200A amplifier in voltage following mode (Molecular
Devices, Berkshire, UK). Responses were digitized at 200 kHz, and
recorded for offline analysis using pClamp software (v10, Molecular
Devices, Berkshire, UK). To assess the conduction velocity CAPs were
evoked at the maximal stimulation of 4 mA and the distance between
the stimulating and recording electrode altered in 0.5 mm increments
from 1–2.5 mm by moving the recording electrode. The post-stimulus
latency of the CAP peak was then recorded and the conduction veloc-
ity calculated based on the distance.
2.5 | Immunohistochemistry
Paraffin sections were cut at 10lm thickness. Free floating cryo-
preserved sections cut at 30 lm thickness were used for the Iba-1,
TMEM119 colocalization. The antibodies used in this study were the
following: Nav1.6 (1:100, AB5580, Millipore, Nottingham, UK), Caspr
(1:50, clone K65/35; UC Davies NIH NeuroMab, USA), Iba-1 (1:1000
for DAB, 1:100 for fluorescence, MP-290-CR05, Menarini, Woking-
ham, UK), (1:4000 for DAB, 1:500 for fluorescence, ab5076, Abcam,
Cambridge, UK), Ki67 (1:25 for VIP labeling, ab16667, Abcam, Cam-
bridge, UK), TMEM119 (1:500, ab209064, Abcam, Cambridge, UK),
MAG (1:500, L20, sc-9543; Santa Cruz Biotechnology, Heidelberg, Ger-
many). Fluorescent secondary antibodies Alexa Fluor 488, 546 and 647
(1:500) and Streptavidin Alexa Fluor 546 (1:100) were purchased from
Life technologies Ltd (Loughborough, UK). Non-fluorescent biotinyl-
ated secondary antibodies were purchased from Vector Laboratories
(Peterborough, UK). All sections were heat-retrieved with either EDTA
pH 8 or citrate pH 6 and primary antibodies were incubated overnight
at 48C in blocking buffer (Iba-1, MAG and Caspr, MAG, Iba-1 triple
label) or blocking buffer with 0.3% Triton X-100 (Nav1.6 and Caspr dou-
ble label). Sections were stained at the outset with haematoxylin and
eosin to determine the presence and absence of ischemic neuronal
perikaryal damage as part of the inclusion/exclusion criteria.
2.6 | Analysis of immunohistochemistry
Immunolabeled 10 mm paraffin sections were analysed using either a
laser scanning confocal microscope Leica SP5 C (Milton Keynes, UK;
fluorescent double and triple label) or an optical microscope Olympus
BX51 (Olympus, KeyMed House, Southend-on-Sea, UK; MAG and Iba-
1). Immunolabeled 30 mm free floating cryo-preserved sections immu-
nostained with Iba-1 and TMEM119 were analyzed using a laser scan-
ning confocal microscope Zeiss LSM710 (Zeiss, Cambridge, UK).
2.6.1 | Node-paranode measures
Images from the corpus callosum of both hemispheres (Interaural
1.98 mm; Bregma 1.82 mm according to Franklin and Paxinos, 1997)
were acquired with a 63x oil-immersion objective (numerical aperture
1.4), a pinhole of 1 Airy unit and a 1024 3 1024 pixel resolution. The
corresponding Nyquist settings, 4.7x zoom and 0.13 mm z-step, were
used to deconvolve the image (Huygens Professional Deconvolution
Software; SVI, Hilversum, The Netherlands). All length measurements
were performed using ImageJ (FIJI) and the observer was blinded to
the surgical procedure.
The nodal gap length, distance between paired Caspr1 rectangular
clusters, and the length of the sodium channel cluster, were measured
in image stacks spanning 6 mm. The first 20 nodes that appeared in
the stack and were not in contact with the borders of the image were
selected for length measurements using the line tool of ImageJ. In
addition, the nodal-paranodal ratio was also calculated dividing the
length of the sodium channel cluster of a given node by its nodal gap
length.
2.6.2 | Iba-1, Ki67, and MAG measures
The loss of axon-glial integrity of the corpus callosum was assessed
using MAG immunostaining and graded from 0 (none) to 3 (extensive).
Myelin damage identified with MAG was determined as the presence
of disorganised white matter fibres and myelin debris. The scale was as
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follows; normal (grade 0), minimal myelin debris, vacuolation, and disor-
ganisation of fibres (grade 1), modest myelin debris, vacuolation, and
disorganisation of fibres (grade 2), and extensive myelin debris, vacuo-
lation, and disorganization of fibres (grade 3). Microglia were identified
using Iba-1 and the number of positively stained cells in the corpus cal-
losum was counted. In order to evaluate proliferation of microglia, Iba-
1 was colabeled with Ki67 and the percentage of Iba-1/Ki67 cells
measured within the corpus collosum.
2.6.3 | Caspr, MAG, and Iba-1 triple label imaging
Images from the corpus callosum with high and low densities of micro-
glial cells (Interaural 1.98 mm; Bregma 1.82 mm) were acquired at dif-
ferent magnifications using a 403 oil-immersion objective (numerical
aperture 1.25) or a 1003 oil-immersion objective (numerical aperture
1.4), a pinhole of 1 Airy unit and a 1024 3 1024 pixel resolution. The
corresponding Nyquist settings were used to deconvolve the images
(Huygens Professional Deconvolution Software; SVI, Hilversum, The
Netherlands).
2.6.4 | Iba-1, TMEM119 double labelling
Images from the corpus callosum (Interaural 1.98 mm; Bregma
1.82 mm) were acquired at 203 magnification (numerical aperture 0.8),
pinhole of 1–2 Airy units and a 1024 3 1024 pixel resolution. Images
were then examined in a blinded manner for Iba-11 TMEM119- cells
within the white matter.
2.7 | Real time quantitative real time polymerase
chain reaction (RT-qPCR)
Corpus callosum was carefully dissected from brain slices adjacent to
those used for electrophysiological analysis. RNA was extracted using
a Qiagen RNeasy® midikit following manufacturer’s instructions. RNA
was further concentrated by precipitation. Briefly, RNA was treated
with 0.3 M sodium acetate and 100% ethanol and incubated overnight
at 2808C to promote precipitation. Samples were then centrifuged at
15,000g for 45 min at 48C and pelleted RNA resuspended in 70%
ethanol and centrifugation repeated. Supernatant was then removed
and samples air dried before reconstituting in RNase/DNase free
water. Contaminating DNA was then removed using an Ambion®
DNA-free kit following manufacturer’s instructions. Complementary
DNA (cDNA) was generated using superscript III reverse transcriptase.
Briefly, RNA was combined with Oligo (dt)15 (Promega, USA) and
deoxynucleotide triphosphates (dNTP; Invitrogen, UK) in DNase/
RNase-free water before heating to 658C for 5 minutes and chilling to
48C using a T100 thermal cycler. Samples were then combined with
5X first strand buffer (Invitrogen, UK), 0.1 M dithiothreitol (DTT; Invi-
trogen, UK), RNasinR Plus Rnase Inhibitor (Promega, USA) and Super-
script III RT (Invitrogen, UK) or RNase/DNase-free water as a control
before heating to 508C for 60 min and 708C for 15 min using a T100
thermal cycler (BioRad, UK). For qRT-PCR analysis the following pri-
mers were designed using Primer BLAST and validated to confirm effi-















Generated cDNA was first combined with forward and reverse pri-
mers, Platinum SYBR Green qPCR Supermix-UDG and ROX reference
dye in DNase/RNase-free water. The thermal profile was then per-
formed using a Stratagene Mx3005P thermocycler (Agilent) of the fol-
lowing steps: denaturation 958C 10 min (1cycle); amplification, 958C 15
sec, 608C 20 sec, 728C 1 min (40cycles); elongation 958C 1 min, 558C
30 sec, 958C 30 sec (1 cycle). Calculated cycle threshold (Ct) values
were normalised to values obtained for the housekeeping gene Gapdh
and the 2^DDCT method was used to determine expression fold change
relative to sham control group.
2.8 | Statistical analysis
Data are presented as mean6 SEMwith the exception of nodal gap and
nodal-paranodal ratio datawhichwere plotted as cumulative and relative
frequency (%), respectively. Electrophysiology data and microglia counts
were analysed using ANOVA and Student’s unpaired t-test. Semi-quali-
tative MAG grading was analysed with Chi-square test for trend and
nodal measureswere analysed using a two-sample Kolmogorov-Smirnov
test. The percentage of Iba1/Ki67 colocalised cells was compared across
groups using KruskalWallis. Correlation analyses were done using either
Pearson or Spearman test depending on parametric or non-parametric
distribution of the data. Unless otherwise indicated, a probability (P)
value of<0.05was considered to be statistically significant.
3 | RESULTS
3.1 | Functional integrity of white matter is
progressively impaired in response to hypoperfusion
To test whether the functional integrity of white matter was altered in
response to increased durations of hypoperfusion, extracellular CAPs
were recorded in the transcallosal area of the corpus callosum. The post-
stimulus latency of the CAP peak, as an index of conduction velocity,
was recorded at different distances (from 1 mm to 2.5 mm from the
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stimulating electrode) in the corpus callosum (Figure 1). Peak latency
increasedwith prolonged durations of hypoperfusion (Figure 1a–c) indic-
ative of an impaired conduction velocity in myelinated tracts. There was
a significant increase in the CAP peak latency after 6 weeks (P<0.05,
Figure 1b,e) and 12 weeks (P<0.001; Figure 1c,f) of hypoperfusion. To
determine if there was any severe functional loss of white matter fibres
in response to hypoperfusion the maximal peak amplitude of the CAP
was compared between groups after increasing the stimulus strength
from 0.25 to 4 mA. There was no significant change in the peak ampli-
tude of myelinated fibres (data not shown) at any time-point studied
indicating a lack of substantial axonal loss in ourmodel of hypoperfusion.
3.2 | Progressive loss of paranodal and internodal
axon-glial integrity in response to hypoperfusion
Our group has previously described alterations in axon-glial integrity in
response to hypoperfusion (Reimer et al., 2011), associated with a dis-
ruption in the structural organisation of key proteins of the paranodal
and internodal axonal domains (Figure 2a). To investigate whether the
nodal-paranodal domains were altered in response to increasing dura-
tions of hypoperfusion, double-labelling of sections with antibodies
against Caspr (paranodes) and Nav1.6 (Node of Ranvier) were performed.
As a measure of paranodal integrity the distance between a pair of par-
anodes (Caspr1 clusters) from the same node (nodal gap length) was
measured at 1 week, 6 weeks, and 12 weeks (Figure 2b–e). Although no
alterations were detected at early time-points (1 week Figure 2f; 6
weeks Figure 2g), a significant reduction in the nodal gap length was
observed after 12 weeks of hypoperfusion (Figure 2h). To examine
whether alterations in the nodal-paranodal integrity could be related
with white matter function the correlation between peak latency and
nodal gap length was tested. Notably there was a significant correlation
between peak latency and nodal gap length in sham animals (Figure 2i;
Spearman r520.38, P<0.05) but no relation between peak latency
and nodal gap length was determined in hypoperfused animals (Figure
2j; Spearman r520.05, P>0.05) suggesting that paranodal integrity is
important for proper axonal function under physiological conditions.
To explore paranodal axon-glial integrity, the nodal-paranodal ratio,
which results from dividing the length of the sodium channel cluster of
a given node by its nodal gap length, was calculated (Figure 3a). In nor-
mal conditions, this ratio is close to 1, since the different proteins of
the axonal domains have a very distinctive and well-defined spatial dis-
tribution with limited over-lap between domains (Figure 3b). Deviations
in this ratio could be indicative of loss of axon-glial integrity (Figure
3b). Consistent with our paranodal integrity results, the nodal-
paranodal ratio was unchanged at early time-points (Figure 3c,d) but
was significantly shifted 12 weeks after surgery (Figure 3e), indicating a
loss of axon-glial integrity with increasing durations of hypoperfusion.
Internodal axon-glial integrity was further assessed using MAG
immunohistochemistry in the corpus callosum.With increasing durations
of hypoperfusion a progressive increase ofmyelin debris and vacuolation
was determined (Figure 3g–i) which was absent in shams (Figure 3f). In
line with paranodal data, no significant differences were found between
groups at early time-points after surgery (1 week: 0.1760.39 sham vs
0.8960.60 hypoperfused P>0.05; 6 weeks: 0.5060.67 sham vs
1.1761.03 hypoperfused P>0.05) but there was a significant effect of
hypoperfusion on axon-glial integrity 12 weeks after surgery (0.836
0.72 sham vs 1.5660.88, P<0.05) further supporting the disruption of
axon-glial integrity in response to hypoperfusion.
FIGURE 1 Progressive impairment of the functional integrity of myelinated axons in response to increased durations of hypoperfusion.
Latency to CAP peak was progressively increased with increasing durations of hypoperfusion (a–c) indicative of impaired conduction
velocity of myelinated axons. There were no significant differences following hypoperfusion at 1 week (a,d) but CAP latency was
significantly increased after 6 weeks (b,e) and further at 12 weeks (c,f). Data are mean6SEM, n59–12/group. * P<0.05, ***P<0.001
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3.3 | Gradual increase of microgliosis relates to
impaired structural and functional integrity of white
matter in response to hypoperfusion
A prominent feature of the model of cerebral hypoperfusion is a robust
increase in microglia number (Coltman et al., 2011; Holland et al.,
2011; McQueen et al., 2014; Reimer et al., 2011). To determine if the
inflammatory response was increased in response to different dura-
tions of hypoperfusion the number of microglial cells was counted in
the corpus callosum of Iba-1 stained sections (Interaural 1.74 mm;
Bregma 2.06 mm). The number of Iba-11 cells gradually increased in
response to prolonged durations of hypoperfusion (Figure 4a–c). As
early as 1 week after hypoperfusion (Figure 4a), microglial numbers
were increased compared to control. At 6 weeks and 12 weeks this
increase in microglia was pronounced and significantly greater than
that observed in controls (P<0.05 Figure 4b,c).
It was then determined whether the increase in Iba-1 positive cells,
found in the corpus callosum post-hypoperfusion, were microglia in ori-
gin or driven by macrophage infiltration. The recently developed micro-
glia specific marker TMEM119 (Bennett et al., 2016) was colocalized
with Iba-1 and quantified to delineate infiltrating macrophage cells from
resident microglia. Representative images are shown of Iba-1 immuno-
staining in sham (Figure 4d) and hypoperfused (Figure 4h); TMEM119
immunostaining in sham (Figure 4e) and hypoperfused (Figure 4i) and
then Iba-1/TMEM119 co-localisation in sham (Figure 4f,g) and hypoper-
fused (Figure 4j,k) white matter. All (100%) Iba-11 cells in both sham
(Figure 4d) and hypoperfused cohorts (Figure 4h) were also TMEM1191
(Figure 4e,i) indicating that the cells in the corpus callosum were micro-
glia and the increase was not driven by macrophage infiltration.
To investigate whether the increase in microglial cells was associ-
ated with the loss of paranodal and axon-glial integrity, the correlations
between nodal gap length and number of microglial cells, and nodal/
paranodal ratio and number of microglial cells were tested. Remarkably,
there was an overall negative correlation between the length of the
nodal gap and the microglial counts (Figure 4l; Spearman r520.55,
P<0.0001), indicating that higher levels of microglia correlate with
reductions in the nodal gap length (i.e. loss of paranodal integrity). In
addition, there was a positive correlation between axon-glial integrity
and microglial number (Figure 4m; Spearman r520.37, P<0.005). To
determine whether the microgliosis could also be related to the
FIGURE 2 Decreased nodal gap length after hypoperfusion. Schematic representation of the axonal domains (a). The nodal gap length, i.e the
distance between two paranodes of the same node, was determined using the paranodal protein Caspr (b). Forty Caspr pairs were analysed per
animal (20 per hemisphere) and these 360–480 nodal gap lengths are plotted as cumulative frequency distribution (f–h). Significant reduction in
the nodal gap length was observed after 12 weeks of hypoperfusion (e,h) but not at earlier time-points (c,f,d,g). There was an overall negative cor-
relation between nodal gap length and peak latency in sham (i) but not in hypoperfused (j) mice (Spearman r520.38, P<0.05; Spearman
r520.05, P>0.05, respectively). n59–12/group. **P<0.01. Scale bar 1 lm [Color figure can be viewed at wileyonlinelibrary.com]
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progressive worsening of white matter function, the correlation
between peak latency and the number of microglial cells was tested.
Interestingly, there was an overall positive correlation between the
number of microglial cells and the peak latency (Figure 4n; Spearman
r50.37, P<0.005), suggesting that higher levels of inflammation relate
to greater deficits in the functional integrity of white matter over time.
Altogether, the results suggest that there might be a direct associa-
tion between hypoperfusion-induced white matter microgliosis and dis-
ruption of paranodal and internodal integrities (Figure 5). Interestingly, it
seems that areas devoid of activated microglia (Figure 5c,g) are associated
with highly organised myelin fibres (Figure 5a,e) and well-preserved Caspr
at paranodes (Figure 5b,f) whereas activated microglia in hypoperfusion
(Figure 5k,o) are associated with disorganized myelinated tracts (Figure 5i,
m) and a loss of paranodal integrity (Figure 5j,n). Since the integrity of axo-
nal domains is critical for efficient neuronal communication, this could
ultimately impact on white matter function and cognition.
3.4 | Minocycline treatment reduces microgliosis and
restores white matter functional integrity after
hypoperfusion
To test whether microglia contribute to the functional impairment of
white matter after hypoperfusion, we investigated the effects of min-
ocycline. Treatment was initiated 1 day after sham or hypoperfusion
surgery and lasted for 10 weeks. Notably, minocycline treatment
effectively restored white matter functional integrity (Figure 6a). The
FIGURE 3 Disrupted axon-glial integrity after hypoperfusion. Schematic to indicate the nodal-paranodal ratio, which is close to 1 in intact
nodes (a), and results from dividing the nodal length of a given node by its nodal gap length which is indicative of axon-glial integrity. (b) Repre-
sentative images to highlight the normal spatial relationship between the node (Nav1.6) and paranodes (Caspr) in a sham and the disruption
with hypoperfusion. Scale bar 1 lm. No differences in the nodal-paranodal ratio were observed after 1 (c) and 6 (d) weeks of hypoperfusion
but it was significantly shifted 12 weeks after hypoperfusion (e) suggesting a loss of nodal-paranodal integrity at this time point. Ratio data is
plotted as relative frequency. n59–12/group. *p <0.05. (f–i) Representative images of myelin-associated glycoprotein (MAG) staining showing
normal tissue (f) and progressive loss of axon-glia integrity in the corpus callosum with increasing durations of hypoperfusion (g–i). Myelin
debris (arrow) and vacuolation (asterisk) were gradually increased after hypoperfusion compared to sham operated mice. Scale bar 25 lm
[Color figure can be viewed at wileyonlinelibrary.com]
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FIGURE 4 Microgliosis is increased in response to hypoperfusion and is associated with structural and functional alterations. Iba-1 labelled
microglia show a progressive increase in the corpus callosum of hypoperfused mice (a-c). The number of microglial cells increased after
hypoperfusion and were significantly greater at 6 (b) and 12 weeks (c) compared with sham (*P<0.05). Representative images of sham (d–
g) and hypoperfusion (h–k) at 12 weeks post-surgery are shown to illustrate Iba-1 immunostaining in sham (d) and hypoperfused (h);
TMEM119 immunostaining in sham (e) and hypoperfused (i) and then Iba-1/TMEM119 co-localisation in sham (f,g) and hypoperfused (j,k)
white matter. All Iba-11 cells in both sham and hypoperfused cohorts were also TMEM1191 indicating that the cells in the corpus callosum
were resident microglia. Scale bars; d-f and h-j are 50mm, g and k 10 mm. The number of microglial cells significantly correlated with nodal
gap length (l; Spearman r50.55, P<0.0001), axon-glial integrity (m; Spearman r50.37, P<0.005) and CAP peak latency (n; Spearman
r50.37, P<0.005). Data are mean6 SEM, n59–12/group. * P<0.05 [Color figure can be viewed at wileyonlinelibrary.com]
FIGURE 5 Gradual increase in microglial cells at the corpus callosum is associated with axon-glial integrity loss. Representative images (a–
p) of a triple staining labelling for MAG (red), Caspr (green), and Iba-1 (white) at low (40x) and high magnification (100x). Areas devoid of
activated microglia (c,g) are associated with highly organised myelin fibres (a,e) and well-preserved caspr pairs (b,f) and gradual increase in
activated microglia (k,o) is associated with disorganized fibre structure (i,m) and loss of paranodal integrity (j,n). Scale bar 40 x 25 lm; scale
bar 100 x 10 lm. Merged images of MAG, Caspr and Iba1 are shown (d,h,l,p) [Color figure can be viewed at wileyonlinelibrary.com]
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peak latency of CAPs was significantly increased in hypoperfused
vehicle treated mice compared to sham vehicle treated mice
(P<0.05). In contrast, minocycline-treated hypoperfused mice had
similar peak latencies to the sham controls (P>0.05) but had signifi-
cantly reduced peak latencies compared to control hypoperfused
mice (P<0.05). Similar to the previous study, hypoperfusion signifi-
cantly increased the number of microglia as compared to sham con-
trols (P<0.05, Figure 6b). However the number of microglia in
minocycline-treated hypoperfused mice were not significantly differ-
ent to that of controls (Figure 6b). We next determined whether
hypoperfusion influenced proliferation of microglia and if this was
affected by minocycline. Iba-1 stained sections were double labelled
with the proliferation marker Ki67 (see representative images Figure
6e). Overall, there was no significant difference in the % of co-
localised Iba-1 immunostained cells with Ki67 (p50.057) between
the groups (sham, hypoperfused vehicle, hypoperfused minocycline
treated). However, it was noted that there was evidence of microglial
proliferation in hypoperfused mice which was absent from sham vehi-
cle treated mice. Further the number of proliferating microglia was
reduced in minocycline treated mice as compared with hypoperfused
vehicle treated mice (Figure 6d).
To further confirm whether the number of microglia could be
related to white matter functional integrity, the correlation between
these measures was tested. Noteworthy, and in line with our previous
results, there was an overall positive correlation between the number
of microglial cells and the latency to CAP peak (Figure 6c; Pearson
r50.57, P<0.002), indicating that increased numbers of microglia are
indeed associated with a worsening of white matter function.
FIGURE 6 Minocycline treatment reduces microgliosis and improves white matter functional integrity. The latency to CAP of myelinated
axons (a) was significantly increased after hypoperfusion and treatment with minocycline restored peak latency values to those of sham
animals. Hypoperfusion significantly increased the number of microglia as compared to sham controls (b). The number of microglia in
minocycline-treated hypoperfused mice were not significantly different to that of controls (b) indicating that minocycline treatment damp-
ened the hypoperfusion-induced microgliosis. The number of microglial cells significantly correlated with peak latency (c; Pearson r50.57,
P<0.002) further highlighting the close association between inflammation and white matter functional integrity. There was no overall dif-
ference in the % double labelled Iba1/Ki67 cells (proliferating microglia) across the groups. Notably proliferating microglia were absent in
shams and present in hypoperfused groups with fewer proliferating cells in the minocycline treated compared to vehicle treated group (d).
Representative images of Iba-1 (brown) and Ki67 (black) immunolabelling; the inserts show microglia and highlights the lack of co-
localisation in sham mice and presence in hypoperfused mice (e). Scale bar 10 lm Data are mean6 SEM, n 59–10/group. * P<0.05 [Color
figure can be viewed at wileyonlinelibrary.com]
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3.5 | Expression of inflammatory genes are not altered
in response to hypoperfusion
To investigate the potential modulation of neuroinflammatory profile
by minocycline in response to hypoperfusion the expression of
selected inflammatory genes were analysed in the corpus callosum via
RT-qPCR (Figure 7) from those cohorts used previously for electro-
physiological and immunohistochemical analysis. Although pronounced
microgliosis was observed in white matter regions in response to hypo-
perfusion only subtle differences in gene expression were observed
suggestive of a chronic low-grade inflammatory response to hypoper-
fusion. Furthermore, consistent alterations in archetypal pro- or anti-
inflammatory genes were not observed with minocycline treatment.
Therefore, although minocycline treatment reduced microgliosis and
improved white matter integrity in response to hypoperfusion the neg-
ligible effects on gene expression are consistent with the subtle under-
lying inflammatory response to hypoperfusion alone.
4 | DISCUSSION
Previous studies, including our own, indicated that disruption of white
matter structure induced by chronic cerebral hypoperfusion (Coltman
et al., 2011; Holland et al., 2011; Reimer et al., 2011; Shibata et al.,
2004) is closely linked with a robust increase in microglia number.
However to date it was unclear whether these structural changes in
white matter are related to a functional impairment in white matter
and second to this whether increased microglia contribute to these
changes. The current study demonstrates that cerebral hypoperfusion
induces a progressive impairment of white matter function which is
closely related to axon-glial disruption and increased numbers of resi-
dent microglia. Furthermore, minocycline, an agent that can inhibit
microglia proliferation and exert anti-inflammatory properties, restores
the functional impairment of white matter integrity caused by chronic
cerebral hypoperfusion related to a reduction in microglia number.
The mouse model of cerebral hypoperfusion used in the current
study has been well characterized by our group and others (Coltman
et al., 2011; Holland et al., 2011, 2015; McQueen et al., 2014; Reimer
et al., 2011; Shibata et al., 2004) and has proven informative in provid-
ing mechanistic insight to cerebral vascular disease in which cerebral
hypoperfusion and white matter damage are central to the pathophysi-
ology. The current study builds on our previous work which demon-
strated the vulnerability of axon-glial domains of myelinated axons to
mild cerebral hypoperfusion (Reimer et al., 2011) and now shows that
these structural changes in white matter are associated with a
FIGURE 7 The effect of minocycline on the inflammatory profile of the corpus callosum in response to prolonged hypoperfusion. RT-qPCR
analysis of gene expression in the corpus callosum following 12 weeks sham, or hypoperfusion or hypoperfusion and minocycline treatment.
Cycle threshold (Ct) values of target genes were normalised to Gapdh and expression fold changes relative to sham group determined using
2^DDCt method. Data show mean6 SEM, n58–10 per group. There were no statistical differences in gene expression between the groups
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pronounced functional impairment of white matter connectivity. It is
widely accepted that the integrity of the brain’s white matter is critical
in regulating efficient neuronal communication and maintaining cogni-
tive function. Rapid saltatory conduction relies on the highly organised
molecular structure of myelinated fibres into distinctive domains com-
prising the node of Ranvier, the paranode, the juxtaparanode and the
internode (Hartline and Colman, 2007). Amongst these domains, the
paranode, that flanks the node of Ranvier in myelinated axons, is a key
region to maintain white matter architecture. The paranodal septate-
like junction, which constitutes the major site of attachment between
the glial cell and the axon, acts as an electrical and biochemical barrier
between axonal domains (Buttermore, Thaxton, & Bhat, 2013) and its
integrity has been proven to be fundamental for proper axonal commu-
nication. For instance, studies using knockout mice deficient for proteins
key in axon-glial connection at paranodal regions such as contactin,
caspr and neurofascin155 show severe reductions in nerve conduction
velocity even in the absence of gross myelin or axon pathology (Bhat
et al., 2001; Boyle et al., 2001; Pillai et al., 2009). Moreover, alterations
in the distribution of these proteins have also been shown to have a
negative impact on axon-glial integrity and axonal function (Hayashi
et al., 2013; Nie et al., 2006; Ritter et al., 2013; Tanaka et al., 2009) and
mathematical models indicate that even subtle paranodal disruption can
significantly influence conduction velocity (Babbs and Shi, 2013).
Another protein essential for axon-glial interaction is MAG which is
selectively localized at the periaxonal space of internodes (Quarles,
2007). Due to its specific location, far from the oligodendrocyte cell
body, MAG has been shown to be more susceptible to hypoxia-like
insults than other internodal proteins such as myelin basic protein or
proteolipid protein (Aboul-Enein et al., 2003; Barker et al., 2013). To
date, most of the white matter functional evidence has been generated
from studies in peripheral nerves and only a few of these measure white
matter function in the CNS (Murcia-Belmonte et al., 2016; Ritter et al.,
2013; Teigler, Komljenovic, Draguhn, Gorgas, & Just, 2009). Notewor-
thy, these CNS studies further support the idea that changes in axonal
domains could influence axonal conduction velocity. Taken together,
current literature suggests that alterations in the distribution and/or
molecular architecture of these discrete domains could have a dramatic
impact on axonal function. Hence, the subtle but significant alterations
observed in the structural architecture of axonal domains in our mild
hypoperfusion model could explain, at least in part, the deficits observed
in conduction velocity. In support of this, nodal gap length measurement
correlated with conduction velocity in normal healthy animals, but not
in the hypoperfused ones, perhaps highlighting the importance of nodal
gap integrity for proper action potential propagation.
In the present study as early as 1 week after hypoperfusion, micro-
glia numbers increase in the corpus callosum (20% increase vs. sham)
and increase further after 6 and 12 weeks after hypoperfusion. Investi-
gation was undertaken to determine whether Iba-1 positive cells were
microglial in origin or driven by macrophage infiltration. To address this
we used the antibody TMEM119 recently described by the Barres
group as specific for microglia and not invading monocytes (Bennett
et al, 2016). Our data convincingly shows 100% overlap between Iba-1
positive cells and TMEM119 positive cells in the white matter in this
model of hypoperfusion. Thus infiltrating monocytes do not appear to
contribute to this pool of Iba-1 labelled cells in the corpus callosum.
This increase in microglia could also be accounted for in part by local
proliferation determined by an increase in Iba-1/Ki67 labelled cells after
hypoperfusion. Noteworthy, the number of microglial cells was signifi-
cantly associated with nodal gap length and axon-glial disruption in our
study. Higher numbers of microglial cells correlated with decreased
nodal gap length and increased paranodal axon-glial disruption, perhaps
supporting the idea that the structural alterations observed in response
to hypoperfusion could be secondary to an inflammatory response.
To test whether there was a causal relation between increased
microglia and impaired white matter function after cerebral hypoperfu-
sion we investigated the effect of minocycline. This drug, can readily
penetrate the blood brain barrier, and it has been shown to improve
white matter structure (Jalal et al., 2015; Yang et al., 2015a; Yrjänheikki
et al., 1999). The current study provided new information to show that
minocycline has beneficial effects both restoring the functional impair-
ment induced by hypoperfusion and reducing microglia number. This
study extends previous reports that have focussed on the effects of
minocycline on white matter structure. Studies using experimental auto-
immune encephalomyelitis mouse models and samples from multiple
sclerosis individuals report an association between local microglial acti-
vation and disruption of nodal-paranodal domains in areas of normal-
appearing white matter. Treatment with minocycline, reduced micro-
gliosis and nodal/paranodal disruption albeit no functional alterations
were investigated (Howell et al., 2010). Minocycline has also been effec-
tively used in models of hypoxia-ischemia insult (Cho, La, Cho, Sung, &
Kim, 2006; Jalal et al., 2015; Ma et al., 2015; Yang et al., 2015b), hyper-
oxia (Schmitz et al., 2014), demyelination (Skripuletz et al., 2010) and
intracerebral haemorrhage (Power et al., 2003; Yan et al., 2015). In these
studies, minocycline significantly reduced microgliosis and promoted
neuroprotection as evidenced by the attenuation of white matter dam-
age (Cho et al., 2006; Jalal et al., 2015; Ma et al., 2015; Schmitz et al.,
2014; Skripuletz et al., 2010; Yang et al., 2015b) but a direct functional
on white matter was not investigated. Our new data demonstrate mino-
cycline has beneficial effects on white matter function. A number of
mechanisms for the mode of action of minocycline have been proposed
in addition to microglia inhibition and anti-inflammatory properties
including effects on other cells such as oligodendrocytes (Moller et al.,
2016). In the present study, the mechanism by which minocycline exerts
protective effects on white matter function remains unclear. There was
evidence that microglial proliferation was reduced with minocycline
treatment. We also measured expression of a range of inflammatory
marker genes (e.g. Nos2, Arg1, Trem1, Trem2, Il10, H2-Aa, Il4ra) in iso-
lated white matter by qPCR. However we did not detect changes in
response to hypoperfusion alone therefore any effects of minocycline
on the inflammatory profile were not possible to determine. This was
perhaps not surprising given the subtle nature of the hypoperfusion
insult. However, to increase the sensitivity of detection future studies
should aim to assess gene alterations in isolated microglia from the
white matter. It is also important that microglia phenotype is defined in
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different models and in disease since this may influence the response to
drug treatment and exert different effects on disease progression.
Whilst the current study would suggest that reducing microglia number
in a model of cerebral hypoperfusion has beneficial effects, in other
studies of severe hypoperfusion occurring after stroke, transplanted
human microglial cells have been shown to exert neuroprotective
effects and improve functional recovery (Narantuya et al,. 2010)
whereas ablating microglia worsens injury (Lalancette-Hebert et al.,
2007; Szalay et al., 2016). At the present time some caution needs to be
exerted in translating these preclinical findings to drug studies in patient
cohorts. It is important that microglial phenotype and broader neuroin-
flammatory environment at the time of drug administration is further
investigated since the response may differ.
In summary, our data show that axonal function in the corpus cal-
losum is progressively impaired in response to mild reductions of blood
flow and is related to disruption of axon-glial integrity and microglial
numbers. Modulation of microglial numbers and phenotype should be
further investigated as potential targets for intervention in cerebral
vascular disease.
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